IL73422A0 - Antihypertensive compositions containing thiazides and some novel such compounds - Google Patents

Antihypertensive compositions containing thiazides and some novel such compounds

Info

Publication number
IL73422A0
IL73422A0 IL73422A IL7342284A IL73422A0 IL 73422 A0 IL73422 A0 IL 73422A0 IL 73422 A IL73422 A IL 73422A IL 7342284 A IL7342284 A IL 7342284A IL 73422 A0 IL73422 A0 IL 73422A0
Authority
IL
Israel
Prior art keywords
thiazide
salts
thiazides
achieve
administration
Prior art date
Application number
IL73422A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24234891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL73422(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL73422A0 publication Critical patent/IL73422A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Eye Examination Apparatus (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL73422A 1983-12-09 1984-11-05 Antihypertensive compositions containing thiazides and some novel such compounds IL73422A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/559,755 US4898729A (en) 1983-12-09 1983-12-09 Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Publications (1)

Publication Number Publication Date
IL73422A0 true IL73422A0 (en) 1985-02-28

Family

ID=24234891

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73422A IL73422A0 (en) 1983-12-09 1984-11-05 Antihypertensive compositions containing thiazides and some novel such compounds

Country Status (17)

Country Link
US (1) US4898729A (xx)
EP (1) EP0154009B1 (xx)
JP (4) JPS60139620A (xx)
AT (1) ATE91416T1 (xx)
AU (2) AU564078B2 (xx)
CA (1) CA1279575C (xx)
DE (1) DE3486177T2 (xx)
DK (1) DK586784A (xx)
FI (1) FI844593L (xx)
GR (1) GR81209B (xx)
IE (1) IE60713B1 (xx)
IL (1) IL73422A0 (xx)
IN (1) IN162797B (xx)
MX (1) MX156438A (xx)
NZ (1) NZ210056A (xx)
PT (1) PT79604B (xx)
ZA (1) ZA848619B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305384A4 (en) * 1986-05-02 1989-06-13 Gaf Corp WATER-SOLUBLE POLYVINYL LACTAM MEDICINE COMPLEXES.
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US5132296A (en) * 1987-08-14 1992-07-21 Cherksey Bruce D Membrane NA+ channel protein and related therapeutic compounds
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
US5994348A (en) 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
IL145546A0 (en) 1999-04-05 2002-06-30 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
EP1250937B1 (en) * 2001-04-09 2009-05-13 Rohm And Haas Company Controlled dissolution of active ingredients
PT2060259E (pt) 2001-11-01 2010-04-26 Spectrum Pharmaceuticals Inc Composições médicas para o tratamento intravesical do cancro da bexiga
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
GB0325605D0 (en) * 2003-11-03 2003-12-10 Novartis Ag Combination of organic compounds
CN101384255A (zh) * 2006-02-09 2009-03-11 癌症治疗公司 使用e09和丙二醇治疗膀胱癌
KR101368997B1 (ko) * 2009-10-20 2014-03-03 재단법인 의약바이오컨버젼스연구단 벤즈티아지드를 유효성분으로 함유하는 항암용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL247297A (xx) * 1959-01-14
US3781430A (en) * 1962-10-30 1973-12-25 Merck & Co Inc Diuretic formulations
FR3608M (fr) * 1964-02-03 1965-10-11 Merck & Co Inc Compositions diurétiques.
NL7508856A (nl) * 1974-08-16 1976-02-18 Merck & Co Inc Werkwijze voor het bereiden van preparaten tegen hypertensie.
FR2314719A1 (fr) * 1975-04-11 1977-01-14 Roussel Uclaf Nouveau medicament notamment diuretique
GB1525296A (en) * 1975-08-04 1978-09-20 Geistlich Soehne Ag Antibacterial compositions
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
GB1509778A (en) * 1975-10-29 1978-05-04 Leo Pharm Prod Ltd Pharmaceutical composition and dosage units thereof
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
CH639273A5 (de) * 1978-09-12 1983-11-15 Hoffmann La Roche Diuretische mittel.
DE3027392A1 (de) * 1980-07-17 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Synergistische kombination eines (beta) -rezeptorenblockers mit einem saluretikum
DE3041812A1 (de) * 1980-11-06 1982-06-16 Hoechst Ag, 6000 Frankfurt Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel
JPS5788117A (en) * 1980-11-21 1982-06-01 Smithkline Corp Gelatin capsule containing triamterene
JPS5933213A (ja) * 1982-07-27 1984-02-23 ミラン・フア−マスウ−テイカルズ・インコ−ポレイテイド 医薬組成物及びその製造方法
JPS5927812A (ja) * 1982-08-05 1984-02-14 Kotobuki Seiyaku Kk ニフエジピン製剤の製造方法
JPS5982314A (ja) * 1982-10-29 1984-05-12 インステイテユト・オルガニチエスコゴ・シンテザ・アカデミイ・ナウク・ラトビイスコイ・エスエスア−ル 抗菌性医薬組成物

Also Published As

Publication number Publication date
IE843148L (en) 1985-06-09
ZA848619B (en) 1985-06-26
DE3486177D1 (de) 1993-08-19
DK586784A (da) 1985-06-10
FI844593L (fi) 1985-06-10
DK586784D0 (da) 1984-12-07
IE60713B1 (en) 1994-08-10
AU7440287A (en) 1987-10-08
DE3486177T2 (de) 1994-03-10
JPH10152441A (ja) 1998-06-09
JPH08253418A (ja) 1996-10-01
CA1279575C (en) 1991-01-29
JPH09278655A (ja) 1997-10-28
AU602899B2 (en) 1990-11-01
EP0154009B1 (en) 1993-07-14
IN162797B (xx) 1988-07-09
FI844593A0 (fi) 1984-11-22
US4898729A (en) 1990-02-06
MX156438A (es) 1988-08-22
JPS60139620A (ja) 1985-07-24
EP0154009A1 (en) 1985-09-11
PT79604B (en) 1986-11-18
GR81209B (en) 1985-04-10
PT79604A (en) 1985-01-01
AU3641484A (en) 1985-06-13
ATE91416T1 (de) 1993-07-15
AU564078B2 (en) 1987-07-30
NZ210056A (en) 1989-01-06

Similar Documents

Publication Publication Date Title
IL73422A0 (en) Antihypertensive compositions containing thiazides and some novel such compounds
IE890868L (en) Anticalculus oral composition
KR870002828A (ko) 치석방지 구강 조성물, 그 제조방법 및 이를 사용한 치석 방지법
GEP19970823B (en) Composition for coating of tooth solid tissues
MY130555A (en) Super absorbent polymer composition
NZ213197A (en) 2,3-dihydrobenzofuran-5-sulphonamide derivatives and pharmaceutical compositions
AU3081389A (en) Anticalculus oral compositions
WO1992013813A3 (en) Improved solubility compound fertilizer compositions
DE3781368T2 (de) Granulierte trikalziumphosphat-zusammensetzungen, geeignet zur tablettierung durch direkte kompression.
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
ES8305581A1 (es) Un procedimiento para la preparacion de una composicion de un polimero de poli-(arilen-eter-sulfona) sulfonado.
RU95119705A (ru) Материал для пломбирования каналов корней зубов ("дентап-r")
GB1511196A (en) Creatinine pyrolidonecarboxylate
JPS5615207A (en) Antihypertensive composition having synergism
DE3564423D1 (en) Purification of 4-fluoro-4'-hydroxy-benzophenone
JPS57100916A (en) Prevention of solidification of glauber's salt
CA2073737A1 (en) A process for producing stable, low oder s,s,s-tributylphosphorotrithioate
ES2023296A6 (es) Composicion oral antibacteriana y anti-placa.
CO4770982A1 (es) Nuevas formulaciones
SU1462871A1 (ru) Комплексная добавка для низкотемпературных тампонажных растворов
SU1137635A1 (ru) Катализатор для получения наполненного полиэтилена